Stock Rating Upgrade
Reflecting improving fundamentals and high Appreciation Potential, the Value Trend Rating for Neogenomics Inc (NASDAQ: NEO) improved during the last several trading days. NEO’s current Value Trend Rating is C and the prior Rating was D. Details supporting this higher rating are included in our next report.
Recent Price Action
On 4/12/24, Neogenomics Inc (NASDAQ: NEO) stock declined by -3.0%, closing at $14.09. However, this decline was accompanied by below average trading volume at 67% of normal. The stock has performed in line with the market over the last nine months and has declined -4.7% during the last week.
Current PriceTarget Research Rating
NEO’s future returns on capital are forecasted to be in line with the cost of capital. Accordingly, the company is expected to continue to be Value Creation neutral.
Neogenomics has a current Value Trend Rating of C (Low Neutral). This VT Rating improved in recent days from D previously. With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing contradictory signals. Neogenomics has a poor Appreciation Score of 24 but a slightly positive Power Rating of 64, with the Low Neutral Value Trend Rating the result.
Be the first to comment